BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 489533)

  • 1. Comparison of haloperidol and thioridazine in geriatric outpatients.
    Solomon K
    J Clin Psychiatry; 1979 Nov; 40(11):495. PubMed ID: 489533
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
    Lingl FA
    Psychosomatics; 1973; 14(4):235-40. PubMed ID: 4604344
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloperidol and thioridazine in treatment of chronic schizophrenics.
    Prasad L; Townley MC
    Dis Nerv Syst; 1966 Nov; 27(11):722-6. PubMed ID: 5925664
    [No Abstract]   [Full Text] [Related]  

  • 9. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind study comparing haloperidol with thioridazine in emotionally disturbed, mentally retarded children.
    Ucer E; Kreger KC
    Curr Ther Res Clin Exp; 1969 May; 11(5):278-83. PubMed ID: 4977399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with haloperidol and thioridazine in stuttering children].
    Valdivieso A
    Rev Chil Pediatr; 1974; 45(6):509-11. PubMed ID: 4467233
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs in old age.
    Birkett DP; Boltuch B
    J Med Soc N J; 1973 Sep; 70(9):647-8. PubMed ID: 4518003
    [No Abstract]   [Full Text] [Related]  

  • 14. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 16. Confusion: the cause is the key.
    MacLennan WJ
    Practitioner; 1999 Mar; 243(1596):209-13. PubMed ID: 10436578
    [No Abstract]   [Full Text] [Related]  

  • 17. Thioridazine improves affective symptoms in schizophrenic patients.
    Dufresne RL; Valentino D; Kass DJ
    Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
    Kenney C; Hunter C; Davidson A; Jankovic J
    J Clin Pharmacol; 2008 Mar; 48(3):379-84. PubMed ID: 18223146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of doxepin and thioridazine in outpatients.
    Glick BS
    Dis Nerv Syst; 1973 Jan; 34(1):37-9. PubMed ID: 4709189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.